Table 2.
Data Collection (T1-T10)
| Measurement Occasion | T1 | T2 | T3-T10 | |||||
|---|---|---|---|---|---|---|---|---|
| Phase | Diagnostic Evaluation | Follow-Up | Acute Phase | Educational Session | BEV Random. | Continuation Phase | Clinic Value | Blinded Evaluations |
| Months from Randomization | −4 | −4 | −3 | −1 | 0 | 1–8 | 4–32 | |
| Demographics | ||||||||
| Patient Background (BKGD) | X | |||||||
| Psychiatric Diagnosis | ||||||||
| Structured Clinical Interview for DSM-IV (SCID) | X | X | X | |||||
| Current MDE (Section A) alone | X | X(1) | X | X (2) | X | X | ||
| Longitudinal Interval Follow-up Evaluation | ||||||||
| Psychiatric Status Rating (LIFE PSR) | X | X | ||||||
| MDE Specifiers and Past MDE (Past MDE) | X | |||||||
| Initial Evaluation Summary (IES) | X | |||||||
| Symptom Severity | ||||||||
| Hamilton Rating Scale for Depression (HRSD) | X | X(6) | X(7) | X | X(2) | X | X | |
| Beck Depression Inventory (BDI) | X | X(7) | X | X(2) | X | X | ||
| Global Assessment of Functioning (GAF) | X | X(6) | X(7) | X | X(2) | X | X | |
| Inventory of Depressive Symptomology | ||||||||
| Self-Report (IDS-SR) | X | X(7) | X | X(2) | X | X | ||
| Pittsburgh Sleep Quality Index (PSQI) | X | X(8,1) | X(9) | X | X(17) | |||
| Somatic Symptoms Scale (SSS) | X(2) | X | ||||||
| Personality | ||||||||
| Schedule for Normal and Abnormal Personality (SNAP) | X(3) | X(4) | X(5) | |||||
| Cognitive | ||||||||
| Attributional Style Questionnaire (ASQ) | X | X | X | X(10) | X | |||
| Beck Hopelessness Scale (BHS) | X | X | X | X | ||||
| Self Control Schedule (SCS) | X | X | X | X | ||||
| Dysfunctional Attitudes Scale (DAS) | ||||||||
| Form A | X | X | X | X(10) | X | |||
| Form B | X(11) | X(12) | ||||||
| Mood Induction | X (11) | X(12) | ||||||
| Interpersonal Functioning | ||||||||
| Social Adjustment Scale (SAS-SR) | X | X(8) | X | X | X(10) | X | ||
| Dyadic Adjustment Scale (DYS) | X | X(8) | X | X | X(10) | X | ||
| Inventory of Interpersonal Problems (IIP) | X | X(8) | X | X | X(10) | X | ||
| Working Alliance Inventory | ||||||||
| Patient Version (WAIC) | X | X | X(16) | |||||
| Therapists Version (WAIT) | X(13) | X(14) | ||||||
| Perceived Criticism Scale (PCS) | X | X | X | X | ||||
| Longitudinal Interval Follow-up Evaluation | ||||||||
| Psychosocial Functioning (LIFE PSF) | X | X | ||||||
| Quality of Life | ||||||||
| Quality of Life Enjoyment and Satisfaction Questionnaire (QOLESQ) | X | X | X | |||||
| Life Events | ||||||||
| List of Threatening Events (LTE) | X | X | X | X | ||||
| Cognitive Therapy Skills Use | ||||||||
| Skills of Cognitive Therapy | ||||||||
| Patient Version (SoCT-P) | X | X | X | |||||
| Observer Version (SoCT-O) | X(13) | X(14) | ||||||
| Treatment Preference | ||||||||
| Patient Attitudes & Expectations Scale (PAES) | X | X(15) | ||||||
| Non-Protocol Treatment | ||||||||
| Longitudinal Interval Follow-up Evaluation Treatment History (LIFE TXHX) | X | X | ||||||
| 1. Acute Phase CT weeks 4, 8, 12 | 9. Continuation phase sessions 1, 3, 5, and 6–10 | |||||||
| 2. Continuation Phase sessions 1–10 (semi-monthly for months 1–2; monthly for months 3–8) | 10. Continuation phase sessions 4 and 8 | |||||||
| 3. Acute Phase CT weeks 1 and 12 | 11. For patients who consent to MI only | |||||||
| 4. Continuation phase session 10 | 12. At months 8, 32, or exit for patients who consent to MI | |||||||
| 5. Month 32 or Exit | 13. At Acute Phase CT weeks 7 and 12 | |||||||
| 6. Repeated at least 5 business days after initial evaluation and within 5 business days of the first Acute Phase CT session | 14. Continuation phase months 4 & 8 for C-CT only | |||||||
| 15. Acute Phase CT week 12 | ||||||||
| 7. Once weekly during Acute Phase CT | 16. At months 4 and 8 for C-CT only | |||||||
| 8. Acute Phase CT Session 1 | 17. At months 12–32 or exit | T=Time | ||||||